Disclosures: Butros Fakhoury: Nothing to Disclose, Leandro Sierra: Nothing to Disclose, Marwan Alsaqa: Nothing to Disclose, Alan Bonder: GSK: Grant/Research Support, Mirium: Grant/Research Support, Gilead: Grant/Research Support, Ipsen: Grant/Research Support, Cymabay: Grant/Research Support, Intercept: Grant/Research Support, Intercept: Consultant, GSK: Consultant, Ipsen: Consultant, Chemobab: Grant/Research Support, Alnylam: Consultant, Thirammune: Consultant, Behnam Saberi: Nothing to Disclose 1283 CHARACTERIZATION AND POST-TRANSPLANT OUTCOMES OF MACHINE PERFUSION ORGANS FOR LIVER RE-TRANSPLANTATION Roy Wang 1 Peter Abt 1 Therese Bittermann 1 , 1 Hospital of the University of Pennsylvania Background: Liver re-transplantation (Re-LT) remains the only treatment for liver graft failure
doi: 10.1093/jn/130.5.1115
In line with in vitro observations, the activities of mitochondrial respiratory complexes I, III, IV and V were significantly reduced in the cortex and hippocampus of both Emx1-Cre+ and CamkII-iCre-inducible AIF3 splicing mice (Fig
One study indicated that patients receiving both concurrent IVC and chemotherapy-radiation experienced significantly longer survival times in some instances up to one full year longer survival- when compared with those receiving only radiation therapy alone